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O B J E C T I V E S This study sought to assess the extent and composition of atherosclerosis contrib-
uting to acute coronary syndrome events in women compared with men.
B A C KG ROUND Pathological studies suggest that plaque composition and burden may differ by sex.
It is unclear whether sex impacts the extent, characteristics, and potential vulnerability of coronary plaques.
METHOD S A total of 697 patients (24% women) with acute coronary syndromes were enrolled in the
prospective, multicenter PROSPECT (Providing Regional Observations to Study Predictors of Events in the
Coronary Tree) study. Three-vessel multimodality intracoronary imaging (quantitative coronary angiography,
grayscale, and radiofrequency intravascular ultrasound [IVUS]) was performed after treatment of the culprit
lesion(s). Events during a median 3.4-year follow-up were ascribed to recurrent culprit versus untreated
nonculprit lesions. The authors performed a post hoc, sex-based subgroup analysis.
R E S U L T S Women were older and had more comorbid disease than men. By angiography, women had
a similar number of angiographic culprit (p 0.53) but fewer nonculprit (p 0.05) lesions, and fewer vessels
with nonculprit lesions (p  0.048) compared with men even after multivariable adjustment (p  0.002). By
IVUS, women had fewer nonculprit lesions (p  0.002), but similar plaque burden (PB) per lesion (55.6% vs.
55.3%; p 0.35), and female sex was not predictive of severe (70%) PB (p 0.052). Plaque rupture was less
common in women (6.6% vs. 16.3%; p 0.002) even after adjusting for comorbidities (p 0.004), as was the
total necrotic core volume (p 0.0001). The frequency of other plaque phenotypes was similar for men and
women including pathological intimal thickening, thin-cap ﬁbroatheromas (TCFA), and thick-cap ﬁbroatheromas.
Rates of major adverse cardiovascular events attributed to culprit and nonculprit lesions at 1-, 2-, and 3-year
follow-up were not signiﬁcantly different between men and women, although women were rehospitalized more
frequently due to culprit lesion–related angina. For men, nonculprit lesion minimal lumen area 4.0 mm2, PB
70%, and TCFA predicted nonculprit MACE at 3 years, whereas for women, only TCFA and PB were predictive.
CONC L U S I O N S The PROSPECT study validates that despite having more comorbid risk factors than
men, women have less extensive coronary artery disease by both angiographic and IVUS measures, and that
lesions in women compared with men have less plaque rupture, less necrotic core and calcium, similar plaque
burden, and smaller lumens. TCFA may also be a stronger marker of plaque vulnerability in women than
men. (J Am Coll Cardiol Img 2012;5:S62–72) © 2012 by the American College of Cardiology Foundation
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S63lthough coronary artery disease (CAD) is the
number 1 cause of mortality in both U.S.
men and women (1), women develop CAD
nearly a decade later in life (2). Whereas
men are more likely to present with sudden death
and acute myocardial infarction (MI) (3,4), women
more commonly develop atypical symptoms and/or
See page S73
angina pectoris (3–6). In addition, pathological
studies suggest that plaque erosions may cause acute
coronary syndromes (ACS) more commonly in
women than men (7,8). Thus, sex may affect plaque
formation, vulnerability, and clinical presentation.
No previous study to our knowledge has been able
to characterize the effect of sex on the extent and
characteristics of CAD in vivo, or to prospectively
evaluate the clinical consequences of existing or pro-
gressive plaque development.
The PROSPECT (Providing Regional Observa-
tions to Study Predictors of Events in the Coronary
Tree) study was a prospective, multicenter natural
history study that used 3-vessel multimodality in-
tracoronary imaging to characterize the coronary
tree before long-term follow-up (9–16). We there-
fore performed an analysis from PROSPECT to
compare sex-based differences in coronary artery
disease extent and composition, and to characterize
lesions contributing to future clinical events.
M E T H O D S
The PROSPECT study design, major inclusion
and exclusion criteria, endpoints, and definitions
have been previously described in detail (9,10). In
brief, 697 patients with ACS (ST-segment eleva-
tion myocardial infarction [STEMI] 24 h, non–ST-
egment elevation myocardial infarction [NSTEMI], or
nstable angina) in whom percutaneous coronary
From the *Yale University Medical Center, Division of Cardiology, New
aven, Connecticut; †Columbia University Medical Center, Division of
ardiology, and the Cardiovascular Research Foundation, New York, New
ork; ‡Mayo Clinic, Division of Cardiology, Rochester, Minnesota; §Car-
diovascular Center Aalst, OLV Hospital, Aalst, Belgium; North Ohio Heart
Center/Elyria Memorial Hospital Regional Medical Center, Elyria, Ohio;
¶Presbyterian Hospital, Department of Cardiology, Matthews, North Carolina;
and the #Thoraxcenter, Erasmus Medical Center, Department of Cardiology,
Rotterdam, the Netherlands. Dr. Maehara has received speaker fees from
Volcano Corp. Dr. Mintz has received grant support and consulting fees from
Volcano and Boston Scientific. Dr. Stone is a consultant for InfraReDx
and Volcano. All other authors have stated that they have no relationships
relevant to the contents of this paper to disclose.b
Manuscript received December 23, 2011; revised manuscript received
January 31, 2012, accepted February 2, 2012.ntervention of 1 or 2 major epicardial coronary
rteries was performed, underwent 3-vessel multi-
odality intracoronary imaging (quantitative coro-
ary angiography [QCA], grayscale IVUS imaging,
nd radiofrequency virtual histology (VH) IVUS
Volcano Corporation, San Diego, California]) in
rder to prospectively characterize the proximal 6 to
cm of the coronary tree before longitudinal
linical follow-up. Patients were enrolled only after
he performance of successful and uncomplicated
ercutaneous coronary intervention of all coronary
esions responsible for the index event, and
fter the completion of any other planned
nterventions. The study was approved by
he institutional review board or medical
thics committee at each participating
enter, and all patients gave written in-
ormed consent.
All baseline and follow-up angiograms
nd IVUS images were analyzed at an
ndependent core angiographic laboratory
y technicians who were blinded to clini-
al outcomes (Cardiovascular Research
oundation, New York, New York). An-
iographic qualitative and quantitative
easurements were obtained for the entire
oronary tree using Medis CMS software
ersion 7.0 (Leiden, the Netherlands). All
ngiographic lesions with at least 30%
isible diameter stenosis were analyzed,
nd reference vessel diameter, minimal
uminal diameter (MLD), and diameter
tenosis were recorded. Nonculprit lesions
ere angiographically defined as lesions
ith visually estimated diameter stenosis
y the core laboratory of 30% not re-
ponsible for the index event. An IVUS
esion was defined by a plaque burden of at
east 40% in at least 3 consecutive frames.
rayscale and radiofrequency IVUS were
erformed using QCU-CMS software
Medis), pcVH 2.1 software (Volcano),
nd proprietary qVH software (developed and val-
dated at the Cardiovascular Research Foundation).
he external elastic membrane and luminal borders
ere contoured for each frame, and quantitative
VUS measurements included the cross-sectional
reas of the external elastic membrane, the lumen,
he plaque and media (cross-sectional area of the
xternal elastic membrane minus the area of the
umen), plaque burden (plaque and media cross-
ectional area divided by the external elastic mem-
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S64(MLA). IVUS lesions were further classified by
means of VH-IVUS as 1 of the following: thin-cap
fibroatheroma (TCFA), thick-cap fibroatheroma
(ThCFA), pathological intimal thickening (PIT),
fibrotic plaque, or fibrocalcific plaque (9). Each
grayscale and VH-IVUS frame and lesion was
coregistered to the angiographic roadmap using
fiduciary branches for alignment, as previously de-
scribed (9).
Patients underwent clinical follow-up at 30 days,
180 days, 365 days, and then yearly for at least 2
years (median follow-up was 3.4 years). An inde-
pendent clinical events committee adjudicated all
clinical events occurring during follow-up as due to
recurrence at the original treated (culprit) lesion, at
a previously untreated nonculprit lesion, or at an
undetermined lesion location (when follow-up an-
giography was not performed). The primary end-
point of interest in the PROSPECT study was
nonculprit lesion related–major adverse cardiac
events (NC-MACE) defined as the composite of
cardiac death, cardiac arrest, MI, or rehospitaliza-
tion due to unstable or progressive angina.
Statistical analysis. Baseline demographics, imaging
characteristics and outcomes were compared ac-
cording to sex. Categorical variables were summa-
rized using percentages and counts, and compared
racteristics According to Sex
Men
(n  530)
Women
(n  167) p Value
56.9 [50.2–65.0] 63.6 [53.4–73.3] 0.0001
16.1% (85/529) 20.6% (34/165) 0.18
1.9% (10/529) 6.7% (11/165) 0.004
2 27.8 [25.2–30.9] 28.3 [24.6–32.3] 0.71
tion 10.8% (57/528) 9.7% (16/165) 0.69
23.2% (117/504) 21.7% (35/161) 0.70
isease* 13.1% (68/521) 15.9% (26/164) 0.36
ion 11.0% (58/529) 11.4% (19/167) 0.88
49.3% (257/521) 42.8% (71/166) 0.14
42.7% (205/480) 48.7% (74/152) 0.20
40.6% (213/524) 64.1% (107/167) 0.0001
6.6% (33/498) 22.0% (35/159) 0.0001
4.0 [3.0–5.0] 4.0 [4.0–5.0] 0.01
failure 1.1% (6/527) 4.2% (7/166) 0.02
7.0 [2.5–18.7] 7.6 [2.6–19.2] 0.65
31.9% (169/530) 25.1% (42/167) 0.10
64.2% (340/530) 70.1% (117/167) 0.16
4.0% (21/530) 4.8% (8/167) 0.64
uartile range] or % (n/N). *CAD  coronary artery disease deﬁned as known
Baseline creatinine clearance 60 ml/min.
in; NSTEMI  non–ST-segment elevation myocardial infarction; STEMI 
cardial infarction; TIMI  Thrombolysis In Myocardial Infarction.using chi-square tests or Fischer exact test where
appropriate. Continuous variables were summarized
as median (interquartile range [IQR]) or mean  1
SD and compared using the parametric Wilcoxon
rank sum test. Outcomes were summarized as
Kaplan-Meier percentages and number of events,
and compared using log-rank tests. A p value of
0.05 was considered statistically significant. Mul-
tivariable linear and logistic regression analyses were
performed to evaluate the impact of female sex and
other confounding baseline risk factors on angio-
graphic, greyscale IVUS, and IVUS-VH lesion and
plaque characteristics. Multivariate Cox models
were used to evaluate the impact of sex on culprit-
related and NC-MACE at 3-year follow-up. The
following list of covariates was used to determine
multivariable predictors; female sex, age, diabetes,
insulin-dependent diabetes, body mass index, hy-
pertension, renal insufficiency, history of congestive
heart failure, STEMI 24 h or NSTEMI on
presentation, total grayscale IVUS length of coro-
nary tree analyzed. In addition to these covariates,
the models assessing culprit lesion MACE included
culprit lesion reference diameter, final culprit lesion
MLD, and acute gain by QCA. Subjects with
multiple lesions were controlled for using general-
ized estimating equations. Another Cox model was
performed to assess sex differences in high-risk
IVUS and VH characteristics in predicting lesion-
level NC-MACE events. High-risk lesion charac-
teristics included in this model were: MLA 4.0
mm2, plaque burden (PB) 70%, and TCFA.
Multivariable models used stepwise selection meth-
ods with entry/stay criteria of 0.1/0.1. The p values,
coefficient and standard errors, odds ratios (ORs) or
hazard ratios and 95% confidence intervals (CIs) are
presented. All statistical analyses were performed
using SAS version 9.2 (SAS Institute, Cary, North
Carolina).
R E S U L T S
Baseline demographics. Of the 697 enrolled pa-
tients, 167 (24%) were women, and 530 (76%) were
men. Women were older and had more insulin-
treated diabetes, hypertension, renal insufficiency,
and heart failure (Table 1). There was no difference
in ACS clinical presentation (unstable angina vs.
NSTEMI vs. STEMI) between men and women.
Baseline angiographic characteristics. By coronary
angiography, women and men had similar numbers
of culprit (1.36  0.61 vs. 1.32  0.70; p  0.53)Table 1. Baseline Cha
Age, yrs
Diabetes
Insulin-treated
Body mass index, kg/m
Prior myocardial infarc
Prior angina
Prior coronary artery d
Prior cardiac intervent
Prior tobacco use
Dyslipidemia
Hypertension
Renal insufﬁciency†
TIMI risk score
Prior congestive heart
Baseline CRP, mg/l
Clinical syndrome
STEMI 24 h
NSTEMI
Unstable angina
Values are median [interq
diameter stenosis 50%. †
CRP  C-reactive proteand fewer nonculprit (2.38  1.84 vs. 2.72  2.03;
n
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S65p  0.05) lesions. After multivariable adjustment,
women had similar vessel size and MLD, but fewer
nonculprit lesions (p  0.005), fewer vessels with
nonculprit lesions (p  0.001) per patient, and non-
culprit lesions were more focal (Table 2). Angio-
graphic characteristics of nonculprit lesions responsi-
ble for future NC-MACE were similar across sexes.
The majority (65%) of MACE-producing nonculprit
lesions were nonobstructive (% diameter stenosis [DS]
50%) at baseline in both men and women.
Culprit lesions (698 in men; 225 in women) were
equally distributed in the left anterior descending
coronary artery (43%), right coronary artery (32%),
and left circumflex coronary artery (25%), with
similar lesion complexity (43% were greater than
American College of Cardiology/American Heart
Association B2 complexity) for both men and
women. There was no difference in culprit vessel
size (men: 2.79 mm and women: 2.72 mm; p 
Table 2. Baseline QCA Characteristics of NC Lesions According t
Men
All NC lesions n  1,417
Number of NC lesions 2.72 2.0
Vessels with NC lesions 1.46 0.9
Total length of NC lesions, mm 20.6 [9.0–38.
Lesion location
Right coronary artery 28.9% (410/1,
Left main artery 0.6% (8/1,41
Left anterior descending artery 39.1% (554/1,
Left circumﬂex artery 31.4% (445/1,
Lesion length, mm 8.3 [5.7–12.
Reference vessel diameter, mm 2.3 [1.9–2.8
Minimal luminal diameter, mm 1.4 [1.1–1.9
Diameter stenosis, % 37.4 [31.8–46
NC lesions responsible for subsequent events n  105
Lesion location
LM 2.5% (2/80)
LAD (or branches) 31.3% (25/80)
LCX (or branches) 32.5% (26/80)
RCA (or branches) 33.8% (27/80)
Any branch 40.0% (32/80)
Lesion length, mm 10.9 [7.9–16.
Reference vessel diameter, mm 2.4 [2.1–3.0
Minimal luminal diameter, mm 1.5 [1.0–1.9
Diameter stenosis, % 39.2 [22.5–54
Lesions with QCA DS% 50% 35.0% (28/80)
Lesions with QCA DS% 70% 5.0% (4/80)
Calciﬁcation 2.5% (2/80)
Eccentricity 1.3% (1/80)
Values are median [interquartile range] or % (n/N).
DS  diameter stenosis; LAD  left anterior descending coronary artery; LCX angiography; RCA  right coronary artery.0.06) or baseline DS. The final lesion MLD after
intervention was significantly smaller for women
than men (2.24 mm vs 2.36 mm, p  0.01), as was
the acute gain (1.49 mm vs 1.61 mm, p  0.006).
Baseline IVUS and VH-IVUS characteristics of nonculprit
lesions. By grayscale IVUS, a total of 3,229 IVUS
onculprit lesions (2,558 lesions in 508 men and
71 lesions in 152 women) were identified and
nalyzed (Tables 3 and 4). Women had fewer
onculprit lesions detected by IVUS than men
median: 4.0 [IQR: 3.0 to 5.0] vs. 5.0 [IQR: 4.0 to
.0]; p 0.002), even after adjusting for differences
n length of IVUS analyzed (p  0.005). Women
ad smaller adjusted mean external elastic mem-
rane area (p  0.0001), MLA (p  0.0001), and
laquemedia area (p  0001). Nonculprit % PB
plaquemedia cross-sectional area/external elastic
embrane cross-sectional area), PB 70%, and the
emodeling index were similar, but women had
ex
Univariate Analysis Female Sex in Mu
Women p Value Coefﬁcient
n  397
2.38 1.84 0.05 0.509
1.29 0.98 0.048 0.282
16.6 [7.0–30.6] 0.008 0.825
27.2% (108/397) 0.50 —
0.3% (1/397) 0.69 —
43.3% (172/397) 0.13 —
29.2% (116/397) 0.41 —
7.6 [5.1–11.3] 0.01 1.747
2.2 [1.8–2.7] 0.01 0.005
1.4 [1.0–1.8] 0.08 0.041
37.3 [31.9–46.9] 0.77 —
n  34
3.8% (1/26) 1.00 —
34.6% (9/26) 0.75 —
26.9% (7/26) 0.59 —
34.6% (9/26) 0.94 —
38.5% (10/26) 0.89
7.3 [5.7–12.5] 0.05 —
2.3 [2.0–3.0] 0.71 —
1.5 [1.0–1.8] 0.85 —
33.6 [17.4–51.2] 0.45 —
32.0% (8/25) 0.78
4.0% (1/25) 1.00
0.0% (0/26) 1.00
0.0% (0/26) 1.00
circumﬂex coronary artery; LM  left main coronary artery; NC  nonculprit; QCAo S
ltivariable Analysis
SE p Value
3 0.183 0.0053
8 0.091 0.0001
4] 1.713 0.0001
417) — —
7) — —
417) — —
417) — —
4] 0.690 0.011
] 0.062 0.936
] 0.059 0.491
.3] — —
— —
— —
— —
— —
7] — —
] — —
] — —
.9] — —
left  quantitative coronary
m
a
(
p
EEM  external elastic m mini
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S66significantly more MLA 4.0 mm2 (p  0.01)
compared with men. After adjustment, nonculprit
lesions in women were characterized by significantly
fewer plaque ruptures (p  0.004) (Fig. 1), less
necrotic core volume (p  0.0001), dense calcium
volume (p  0.001), fibrous tissue volume (p 
0.0001), and fibrofatty volume (P  0.0001)
(Table 4). Other VH plaque phenotypes were similar
for men and women, including PIT, TCFA, and
ThCFA. More women had at least 1 lesion with
MLA 4 mm2 (p  0.01), and more had at least 1
high-risk lesion characteristic (p  0.01); more men
had at least 1 lesion with PB 70% (p 0.007), and
en more frequently than women had complete
bsence of high-risk lesion characteristics (p  0.01)
Table 4).
Outcomes according to sex. Major adverse event rates
at 1-, 2-, and 3-year follow-up were similar across the
sexes (Table 5, Fig. 2). Nonculprit MACE at 3 years
was similar for men and women after risk adjustment
(p  0.5). The presence of diabetes mellitus was the
only independent clinical risk factor of nonculprit
S Characteristics of Coronary Tree According to Sex
Univariate Analysis
Men
(n  508)
Women
(n  152)
yzed, mm 175.5 [137.4–217.2] 166.5 [125.3–210.
patient 5 [4–6] 4 [3–6]
s 17.5% (89/508) 13.8% (21/152)
16.3% (83/508) 6.6% (10/152)
2,558 671
11.5 [5.9–21.8] 10.6 [5.2–20.5]
6.0 [4.4–8.3] 5.2 [4.0–7.0]
18.6% (475) 24.1% (162)
2.5 [2.1–3.0] 2.3 [2.0–2.7]
55.6 [49.1–63.2] 55.3 [49.1–61.8]
% 9.2% (236) 7.7% (52)
3/mm 16.0 [12.3–20.5] 13.9 [10.6–16.9]
m3/mm 8.1 [6.1–10.6] 7.0 [5.4–8.8]
a area, mm3/mm 7.7 [5.8–10.0] 6.6 [5.1–8.3]
olume, mm3 84.9 [40.4–179.5] 67.5 [30.6–145.7
47.8 [44.1–52.0] 47.4 [43.8–51.3]
0.93 [0.85–1.00] 0.94 [0.85–1.00]
uent events n  42 n  12
25.6 [16.8–41.4] 24.3 [8.2–35.2]
26.2% (11/42) 8.3% (1/12)
7.1% (3/42) 8.3% (1/12)
57.1% (24/42) 50.0% (6/12)
% 50.0% (21/42) 33.3% (4/12)
artile range] or % (n/N).
embrane; IVUS  intravascular ultrasound; MLA  minimal lumen area; MLD MACE at 3 years in the overall study (OR: 1.68;95% CI: 0.99 to 2.87, p  0.05). There were no
independent clinical predictors identified for either
the male or female populations, likely due to small
event rates in the subgroups.
A separate lesion-level multivariable model was
performed to identify sex differences in high-risk
IVUS and VH lesion characteristics predictive of
subsequent nonculprit lesion MACE. In men,
MLA 4.0 mm2 (OR: 3.80; 95% CI: 1.75 to 8.26,
 0.0007), TCFA (OR: 2.42; 95% CI: 1.27 to
4.62, p  0.007), and PB 70% (OR: 5.98; 95%
CI: 2.75 to 13.01, p 0.0001) were all independent
predictors of subsequent NC-MACE; for women,
TCFA (OR: 9.01; 95% CI: 2.44 to 33.20, p 
0.001) and PB (OR: 4.02; 95% CI: 1.13 to 14.37,
p  0.03) were the only predictors, whereas MLA
4 mm2 was not significant.
Culprit lesion revascularization rates were similar
overall (Table 5, Fig. 2), but women had higher
rates of culprit lesion rehospitalization for worsen-
ing angina at 1-year (7.6% vs. 3.6%; p  0.04),
2-year (11.6% vs. 5.1%, p  0.005), and 3-year
Female Sex in Multivariable Analysis
p Value Coefﬁcient SD Error p Value
0.07
0.002 0.509 0.183 0.005
0.28 — — —
0.002 0.949 0.330 0.004
0.05 — — —
0.0001 0.830 0.145 0.0001
0.001 0.307 0.125 0.014
0.0001 0.041 0.059 0.491
0.35 — — —
0.23 — — —
0.0001 2.626 0.288 0.0001
0.0001 1.182 0.164 0.0001
0.0001 1.421 0.159 0.0001
0.0001
0.09 — — —
0.65 — — —
0.33 — — —
0.26 — — —
1.00 — — —
0.66 — — —
0.31 — — —
mal lumen diameter; NC  nonculprit.Table 3. Baseline IVU
Total IVUS length anal 4]
Number of NC lesions/
Echolucent NC plaque
Ruptured NC plaques
Number of NC lesions
Lesion length, mm
MLA, mm2
MLA 4 mm2
MLD, mm
Plaque burden, %
Plaque burden 70
Mean EEM area, mm
Mean lumen area, m
Mean plaquemedi
Plaque and media v ]
Plaque volume, %
Remodeling index
NC lesions with subseq
Lesion length, mm
Echolucent plaques
Ruptured plaques
MLA 4 mm2
Plaque burden 70
Values are median [interqu(11.6% vs. 6.7%; p  0.04) follow-up compared
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S67with men. After multivariable adjustment, female
sex was not an independent predictor of culprit
lesion MACE at follow-up (p  0.3); however,
culprit lesion acute gain was predictive (OR: 0.55;
95% CI: 0.37 to 0.80, p  0.002).
D I S C U S S I O N
This sex-based analysis from the PROSPECT
study demonstrates that despite being older and
having more comorbid risk factors, after adjusting
for these differences, women presenting with ACS
have less extensive CAD than men as evidenced by
fewer and more focal nonculprit lesions, and fewer
vessels with angiographic nonculprit lesions. Non-
culprit lesions in women had smaller MLA, and
women had more lesions with MLA 4.0 mm2
even after adjusting for differences in BSA and risk
factors, but % PB and PB 70% were similar to
men. Nonculprit lesions in women were character-
ized by significantly less plaque rupture, necrotic
core volume, dense calcium, fibrous and fibrofatty
Table 4. Baseline VH Characteristics of NC Lesions According to
Lesions by VH IVUS
Fibrotic plaque
Fibrocalciﬁc plaque
Pathological intimal thickening 3
Fibroatheroma 6
Thin-cap ﬁbroatheroma 2
Thick-cap ﬁbroatheroma 3
Total necrotic core volume, mm3
Total dense calcium volume, mm3
Total ﬁbrous tissue volume, mm3
Total ﬁbrofatty volume, mm3
NC lesions with subsequent events
Fibrotic plaque
Fibrocalciﬁc plaque
Pathological intimal thickening 1
Fibroatheroma 8
Thin-cap ﬁbroatheroma 4
Thick-cap ﬁbroatheroma 4
High-risk IVUS nonculprit lesion characteristics
Patients with 1 lesions with MLA 4 5
Patients with 1 lesions with PB 70% 3
Patients with 1 TCFAs 5
Patients with none of these 3 characteristics 2
Patients with 1 lesions with 1 of these 3 characteristics 7
Values are % (n/N) or median [interquartile range].
PB  plaque burden; TCFA  thin-cap ﬁbroatheroma; other abbreviations astissue. Other VH plaque phenotypes, including aPIT, TCFA, and ThCFA, were similar for men
and women. More women had at least 1 NC lesion
with MLA 4.0 mm2, and more had at least 1
onculprit high-risk lesion characteristic, whereas
en more often had at least 1 nonculprit lesion
ith PB70%, and more men had a complete
bsence of high-risk characteristics. NC-MACE
ates at 3 years were not significantly different in
en and women in this study; however, identifying
TCFA in women appears to be more predictive of
ACE than in men. Women were rehospitalized
ore often for culprit lesion–related worsening
ngina. This difference was not sex related but
ather was predicted by a worse acute gain after
ulprit lesion intervention.
The PROSPECT sex substudy provides impor-
ant insights into the effect of sex on atherosclerotic
laque development, disease progression, and
arkers of plaque vulnerability.
Atherosclerosis is a progressive inflammatory
rocess (17). Early angiographic studies found that
Univariate Analysis
Fema
Multivari
Men Women p Value Coefﬁcient S
 2,273 n  607
(50/2,273) 3.6% (22/607) 0.05 —
(22/2,273) 1.8% (11/607) 0.08 —
(830/2,273) 34.9% (212/607) 0.47 —
(1371/2,273) 59.6% (362/607) 0.76 —
(506/2,273) 22.4% (136/607) 0.94 —
(865/2,273) 37.2% (226/607) 0.71 —
[1.5–13.3] 3.7 [1.2–10.6] 0.002 3.576
[0.5–5.9] 1.4 [0.4–5.1] 0.01 2.068
[11.3–60.7] 19.5 [7.4–43.4] 0.0001 17.598
[3.3–20.8] 5.0 [2.0–13.2] 0.0001 6.443
n  39 n  11
(0/39) 0% (0/11) NA —
(1/39) 0% (0/11) 1.00 —
(4/39) 18.2% (2/11) 0.60 —
(34/39) 81.8% (9/11) 0.64 —
(17/39) 72.7% (8/11) 0.09 —
(17/39) 9.1% (1/11) 0.07 —
(268/508) 64.5% (98/152) 0.01 0.356
(177/508) 28.3% (43/152) 0.13 0.638
(251/466) 53.8% (77/143) 1.00 —
(114/508) 13.2% (20/152) 0.01 0.470
(394/508) 86.8% (132/152) 0.01 0.470
bles 2 and 3.Sex
le Sex in
able Analysis
D Error p Value
n
2.2% — —
1.0% — —
6.5% — —
0.3% — —
2.3% — —
8.1% — —
4.6 0.855 0.0001
1.9 0.590 0.001
27.4 2.689 0.0001
9.0 1.290 0.0001
0% — —
2.6% — —
0.3% — —
7.2% — —
3.6% — —
3.6% — —
2.8% 0.215 0.097
4.8% 0.235 0.007
3.9% — —
2.4% 0.289 0.103
7.6% 0.289 0.103cute events often arise from non-hemodynamically
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S68significant lesions that were often angiographically
mild (18–20), thus precluding prediction of future
events by angiography alone. Our results confirm
that for both men and women, approximately 65%
of nonculprit lesions responsible for subsequent
events are hemodynamically insignificant (DS
50%), with fewer than 5% of event-provoking
lesions having a 70% stenosis on initial angiogra-
phy. IVUS studies have demonstrated that culprit
lesions in patients with ACS have large PBs (21,22).
his observation is born out in PROSPECT as well,
where nonculprit lesions associated with subsequent
events had higher plaque burdens for men and
women. Virmani et al. have shown in pathological
studies that TCFAs containing a thin fibrous cap
and large necrotic core are more prone to plaque
rupture with subsequent thrombosis than other
lesion phenotypes (23,24), resulting in increasing
interest to use VH-IVUS (and other invasive and
noninvasive techniques) in vivo to define character-
istics of plaque vulnerability (21,25,26). The overall
PROSPECT study demonstrated that “high-risk”
lesions that are likely to be responsible for future
unanticipated MACE arising from untreated seg-
ments of the coronary tree are usually angiographically
mild, but are characterized by large PB, small MLA,
and/or are TCFAs as assessed by VH-IVUS (9).
In PROSPECT, women with ACS at the time of
presentation were substantially older than men, and
had more comorbid conditions, such as diabetes, that
Figure 1. A 72-Year-Old Male With STEMI
The right coronary artery was occluded. After stenting the culprit le
distal vessel (yellow arrow in angiography and yellow triangle in I
coronary intervention.have been associated with increased rates of coronaryevents. Nonetheless, the results of the present study
are consistent with prior autopsy series that found that
men have more extensive atherosclerosis burden than
women (23,27). Women in PROSPECT did have
fewer total lesions and fewer affected vessels than men;
however, PB per lesion and severe PB 70% were
similar and independent of sex, as previous IVUS
studies have suggested (28,29). It is unclear whether
the influence of risk factors (such as diabetes) on
plaque development varies between the sexes; it is
clear, however, that 7 to 8 more years are required for
women to develop atherosclerotic lesions as severe as
those in men.
Prior studies reported that men with ACS are more
likely to have ruptured plaques (30,31), whereas
women were more likely to present with plaque
erosion (7,8), suggesting that the mechanism of ACS
development in men and women may differ. Patients
presenting with plaque erosions are more likely to
have a longer indolent period of angina as opposed to
those with ruptured plaques who present more sud-
denly (32,33). Consistent with these previous obser-
vations, our study found that women were signifi-
cantly less likely to have nonculprit plaque ruptures
than men. Thus, this may partly explain why women
with ACS present later than men and with anginal
symptoms (typical or atypical) rather than full-blown
ACS (3,34). Estrogen has been suggested to retard
plaque development, stabilize existing plaques, and
prevent plaque rupture in women (35). These effects
, intravascular ultrasound (IVUS) showed plaque rupture in the
). No event occurred in the following 3 years. PCI  percutaneoussion
VUSmay be protracted, given the fact that the average age
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S69of women in PROSPECT was 65 years, therefore
mostly postmenopausal, in whom estrogen levels
would have diminished.
Variations in plaque composition between men
and women found in this analysis may have also
contributed to the lower plaque rupture rates in
women. Although the overall distribution of lesion
phenotypes in men and women were comparable,
nonculprit lesions in women were characterized by
less necrotic core volume, less dense calcium vol-
ume, and less fibrous and fibrofatty tissue compared
with men. Calcified plaques have been associated
ith greater clinical stability and less advanced ath-
rosclerosis (36). Although atherosclerotic plaques in
omen have less necrotic core volume and are less
rone to rupture, a different underlying mechanism
Table 5. Clinical Outcomes Attributable to Recurrence at the In
Culprit-Related Events
Men
(n  530)
Women
(n  167) p
1-yr follow-up
MACE 6.8% (34) 11.3% (18) 0
Cardiac death 0.0% (0) 0.6% (1) 0
Cardiac arrest 0.0% (0) 0.0% (0)
Myocardial infarction 1.4% (7) 0.0% (0) 0
Cardiac death, arrest, or MI 1.4% (7) 0.6% (1) 0
Rehospitalization 5.8% (29) 10.8% (17) 0
For unstable angina 1.6% (8) 3.8% (6) 0
For increasing angina 4.2% (21) 9.5% (15) 0
Revascularization 6.2% (31) 8.9% (14) 0
2-yr follow-up
MACE 10.0% (49) 15.8% (25) 0
Cardiac death 0.0% (0) 0.6% (1) 0
Cardiac arrest 0.4% (2) 0.0% (0) 0
Myocardial infarction 2.2% (11) 0.7% (1) 0
Cardiac death, arrest, or MI 2.2% (11) 1.3% (2) 0
Rehospitalization 8.4% (41) 14.7% (23) 0
For unstable angina 3.3% (16) 5.7% (9) 0
For increasing angina 5.9% (29) 13.4% (21) 0
Revascularization 8.8% (43) 12.8% (20) 0
3-yr follow-up
MACE 12.0% (58) 15.8% (25) 0
Cardiac death 0.0% (0) 0.6% (1) 0
Cardiac arrest 0.4% (2) 0.0% (0) 0
Myocardial infarction 2.5% (12) 0.7% (1) 0
Cardiac death, arrest, or MI 2.5% (12) 1.3% (2) 0
Rehospitalization 10.6% (51) 14.7% (23) 0
For unstable angina 4.0% (19) 6.4% (10) 0
For increasing angina 8.0% (38) 13.4% (21) 0
Revascularization 10.4% (50) 12.8% (20) 0
Values are % (n).
MACE  major adverse cardiac events; MI  myocardial infarction.ay lead to ischemic symptoms and cardiac events inwomen. Other higher-risk plaque characteristic of
women including less calcium, a smaller MLA, more
MLA 4.0 mm2, and significantly less total fibrous
volume, may help explain the similar cardiovascular
event rates of cardiac death and MI during 3 years of
follow-up, despite women having less extensive coro-
nary atherosclerosis. Another important insight from
our study is that despite similar IVUS and VH
“high-risk” plaque phenotypes between men and
women, a TCFA may identify a more vulnerable
lesion in women than men. Furthermore, women
were more likely to have at least 1 high-risk plaque
feature compared with men, and the attributable risk
of MACE associated with these high-risk features
(MLA 4.0 mm2, PB 70%, TCFA) appears to
differ by sex, with highest risk associated with TCFA
Culprit Lesion or Untreated Nonculprit Lesions According to Sex
Nonculprit-Related Events All
ue
Men
(n  530)
Women
(n  167) p Value
Men
(n  530)
W
(n
6.1% (30) 7.5% (12) 0.49 12.4% (62) 15
0.0% (0) 0.0% (0) — 0.6% (3) 0
0.0% (0) 0.0% (0) — 0.2% (1) 0
0.4% (2) 0.0% (0) 0.42 2.0% (10) 0
0.4% (2) 0.0% (0) 0.42 2.4% (12) 0
5.6% (28) 7.5% (12) 0.38 10.5% (52) 15
1.4% (7) 2.5% (4) 0.34 3.4% (17) 5
4.2% (21) 5.7% (9) 0.45 7.9% (39) 13
5.9% (29) 5.6% (9) 0.94 11.1% (55) 12
8.8% (43) 11.5% (18) 0.31 16.4% (81) 23
0.0% (0) 0.0% (0) — 1.0% (5) 1
0.0% (0) 0.0% (0) — 0.6% (3) 0
0.4% (2) 0.7% (1) 0.72 2.9% (14) 2
0.4% (2) 0.7% (1) 0.72 3.7% (18) 3
8.4% (41) 10.8% (17) 0.34 14.2% (70) 21
2.0% (10) 4.5% (7) 0.10 5.9% (29) 9
6.8% (33) 7.6% (12) 0.68 11.0% (54) 18
8.2% (40) 9.6% (15) 0.59 14.2% (70) 17
11.3% (54) 12.9% (20) 0.53 18.9% (92) 25
0.0% (0) 0.0% (0) — 1.4% (7) 3
0.0% (0) 0.0% (0) — 0.6% (3) 0
1.1% (5) 0.7% (1) 0.67 3.8% (18) 2
1.1% (5) 0.7% (1) 0.67 5.0% (24) 4
10.4% (50) 12.2% (19) 0.48 16.3% (79) 21
2.7% (13) 5.2% (8) 0.13 7.1% (34) 11
8.3% (40) 9.0% (14) 0.75 13.1% (63) 19
10.5% (50) 11.0% (17) 0.81 16.7% (81) 18itial
Events
Val
omen
 167) p Value
.08 .7% (25) 0.31
.08 .6% (1) 0.98
— .0% (0) 0.57
.13 .0% (0) 0.07
.44 .6% (1) 0.16
.04 .1% (24) 0.12
.10 .7% (9) 0.21
.01 .9% (22) 0.02
.28 .0% (19) 0.76
.05 .4% (37) 0.06
.08 .9% (3) 0.39
.42 .0% (0) 0.33
.20 .0% (3) 0.51
.45 .2% (5) 0.76
.02 .0% (33) 0.05
.16 .6% (15) 0.12
.002 .5% (29) 0.01
.15 .9% (28) 0.29
.17 .5% (40) 0.08
.08 .3% (5) 0.16
.42 .0% (0) 0.33
.16 .0% (3) 0.28
.38 .6% (7) 0.81
.13 .7% (34) 0.10
.18 .1% (17) 0.11
.03 .1% (30) 0.05
.36 .6% (29) 0.55for women and PB 70% for men.
s
fi
T
t
e
w
p
t
O
s
t
w
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 5 , N O . 3 , S U P P L S , 2 0 1 2
M A R C H 2 0 1 2 : S 6 2 – 7 2
Lansky et al.
Sex and Coronary Artery Plaque Characteristics
S70Women were more likely to be rehospitalized for
recurrent angina related to the culprit lesion com-
pared with men, possibly the result of differences in
symptoms as has been described previously
(3,34,37–39). However, the only important predic-
tor of culprit lesion MACE was acute procedural
results (acute lesion gain), which were significantly
lower in women, and likely explain the higher
culprit-related angina and rehospitalization rates in
women.
Study limitations. Although sex was a pre-specified
ubgroup analysis of the PROSPECT trial, the
ndings of this study remain hypothesis-generating.
Figure 2. Kaplan-Meier Time-to-Event Curves of 3-Year MACE in
(A) Kaplan-Meier time-to-event curve of 3-year major adverse cardia
nal treated (culprit) lesion, at a previously untreated nonculprit lesi
event curve of 3-year MACE in women according to disease recurre
nonculprit lesion, or at an undetermined lesion location.he number of women enrolled was modest, andhe study was not powered to detect small differ-
nces in clinical outcomes between men and
omen. Although multivariable adjustment was
erformed for significant confounders, it is possible
hat unmeasured confounders may affect our results.
nly patients with ACS were included in this
tudy; thus, no conclusions can be drawn regarding
he progression of stable angina in men versus
omen.
C O N C L U S I O N S
The underlying composition of atherosclerotic
men and Men
vents (MACE) in men according to disease recurrence at the origi-
r at an undetermined lesion location. (B) Kaplan-Meier time-to-
at the original treated (culprit) lesion, at a previously untreatedWo
c e
on, o
nceplaque differs in men and women presenting with
L
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S71ACS. Despite more comorbid risk factors than
men, women have less extensive coronary artery
disease by both angiographic and IVUS measures.
Plaque morphology and composition in women is
characterized by less plaque rupture, less necrotic
core and calcium, similar PB, but smaller MLA and
more lesions with an MLA of 4.0 mm2, indepen-
dent of body mass and other comorbidities. Plaque
vulnerability characteristics appear to differ by sex,
with the highest risk associated with TCFA inJ Am Coll Cardiol 2010;55:122–32.
1
1
1
1
1
1
1
2012;5 Suppl S:S95physiology of CAD leading to ACS is apparently
different between men and women, although these
differences appear to balance out and did not impact
culprit- or nonculprit–related clinical outcomes be-
tween the sexes.
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